MyFinsight
Home
About
Contact
vtgn: the income statement
Download
Download image
Comprehensive loss
-$19,404K
(-49.94%↓ Y/Y)
Unrealized gain on
marketable securities
$13K
(-35.00%↓ Y/Y)
Net loss
-$19,417K
(-49.81%↓ Y/Y)
Loss before income
taxes
-$19,417K
(-49.89%↓ Y/Y)
Other income
$6K
Interest income, net
$630K
(-50.51%↓ Y/Y)
Loss from operations
-$20,053K
(-40.95%↓ Y/Y)
Total revenues
$258K
(40.98%↑ Y/Y)
Total operating
expenses
$20,311K
(40.95%↑ Y/Y)
General and
administrative
$4,396K
(4.79%↑ Y/Y)
Research and development
$15,915K
(55.80%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Vistagen Therapeutics, Inc. (VTGN)
Vistagen Therapeutics, Inc. (VTGN)